AEAsena Esra Erdem

Asena Esra Erdem

*This is an algorithmically generated author record based on publicly available information.

Asena Esra Erdem has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • DIVA (Differentiating Infected from Vaccinated Animals) Aşı ve Stratejileri

    by Asena Esra Erdem, Barış SAREYYÜPOĞLU

    In veterinary medicine, vaccination is one of the most effective techniques for control and prevention of diseases. When other methods fail in control of animal diseases, different vaccines and strategies are developed. DIVA (Differentiating Infected from Vaccinated Animals) vaccines lacking one or more antigenic epitope(s)/ protein(s) in the prevailing field strain and the accompanying diagnostic tests are effective in eradication and control of diseases. While currently used vaccines can not distinguish between vaccinated and infected animals, DIVA vaccines can be very useful for the purpose. Serological tests, such as ELISA (Enzyme-Linked ImmunoSorbent Assay), used together with DIVA vaccines, can be used to determine which animals are infected and which are vaccinated. DIVA vaccines and strategies for some animal diseases have been developed and continue to be developed. In this review, it is aimed to explain the general characteristics, importance, production, advantages of DIVA vaccines and strategies and their use in various animal diseases.


  • Frequency of Staphylococcus pseudintermedius in Canine Skin Infections and Antibiotic Resistance Profiles of the Recovered Isolates

    by İ̇nci Başak MÜŞTAK, Hamit Kaan Müştak, Seyyide Sariçam, Tuğçe ÜSTÜN, Asena Esra Erdem

    In this study, 61 Staphylococcus pseudintermedius strains were isolated from 77 dogs with skin infections. Antimicrobial resistance to commonly used antibiotics was evaluated by disc diffusion method. The presence of the blaZ and mecA genes responsible respectively for penicillin and methicillin resistance were investigated by PCR. The S. pseudintermedius isolates were highly resistant to tetracycline (47.5%) and penicillin (40.9%) while all isolates were susceptible to amikacin (100%). All 18 methicillin-resistant S. pseudintermedius (MRSP) strains were positive for the mecA gene while the 25 S. pseudintermedius strain isolates with the blaZ gene were also resistant to penicillin phenotypically. Of the 18 MRSP isolates, 14 S. pseudintermedius strains were resistant to three or more antibiotics, indicating that these strains showed multiple drug resistance (MDR). This report confirms previous findings that S. pseudintermedius is the most frequently isolated bacteria from dog skin infections. It can also be concluded that amikacin is a useful agent for treating S. pseudintermedius infections since all the S. pseudintermedius strains tested in this study were susceptible to amikacin.